LUPIN
Back to Balance Sheet
|
LUPIN Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹12,651 Cr | ₹8,961 Cr | ₹8,502 Cr | ₹9,265 Cr | ₹8,276 Cr |
What is the latest Total Current Liabilities ratio of LUPIN ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹12,651 Cr |
| Mar2025 | ₹8,961 Cr |
| Mar2024 | ₹8,502 Cr |
| Mar2023 | ₹9,265 Cr |
| Mar2022 | ₹8,276 Cr |
How is Total Current Liabilities of LUPIN Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹12,651 Cr | 41.17 | |
| Mar2025 | ₹8,961 Cr | 5.41 | |
| Mar2024 | ₹8,502 Cr | -8.24 | |
| Mar2023 | ₹9,265 Cr | 11.95 | |
| Mar2022 | ₹8,276 Cr | - | |
Compare Total Current Liabilities of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹89,345.0 Cr | -0.3% | -6.6% | -0.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | -0.3% |
-6.6% |
-0.7% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses